Phase Ib/II study of an IL-2/T-cell receptor fusion protein in combination with gemcitabine and cisplatin in advanced or metastatic chemo-refractory urothelial cancer (UC).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mayer N. Fishman, Daniel A. Vaena, Parminder Singh, Joel Picus, Ulka N. Vaishampayan, Joel Slaton, John Francis Mahoney, Sanjiv S Agarwala, Charles Joel Rosser, Danny Landau, Julio Hajdenberg, Peter J. Van Veldhuizen, Rahul Atul Parikh, Sarah Alter, Liza Hernandez, Peter Rhode, Hing C. Wong
Institutions: Moffitt Cancer Center, University of Iowa, Iowa City VA Medical Center, University of Arizona Cancer Center, Washington University in St. Louis, Wayne State University, The Barbara Ann Karmanos Cancer Institute, St. Luke's Hospital, University of Hawaii Cancer Center, Orlando Health, University of Kansas Medical Center, University of Pittsburgh Medical Center, Altor BioScience (United States)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2499155383